Both in R&D — Physical & Biological Sciences
OmniAb vs MaxCyte
Over the past year OABI returned +250.0% and MXCT returned −13.7%; their daily moves had a correlation of 0.29.
OABI +250.0% MXCT −13.7%Growth of $1, one year, split-adjusted
| Metric | OABI | MXCT |
|---|---|---|
| Price | $5.18 | $1.39 |
| Market cap | $755.6M | $143.5M |
| Today | +0.58% | −4.79% |
| 1 month | +19.1% | +27.5% |
| 6 months | +262.2% | +64.2% |
| Year to date | +180.0% | −10.3% |
| 1 year | +250.0% | −13.7% |
| Revenue growth (YoY) | +78.3% | −14.5% |
| Gross margin | 92.3% | 77.0% |
| Net margin | −393.9% | −122.0% |
| P/E (TTM) | — | — |
| Price / sales | 18.8× | 4.6× |
| Net cash | $64.2M | $105.7M |
| Dividend yield | — | — |
| Volatility (60d) | 71.6% | 82.3% |
| Short % of float | 9.7% | 2.0% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).